Filters
Results 1 - 10 of 2297
Results 1 - 10 of 2297.
Search took: 0.026 seconds
Sort by: date | relevance |
AbstractAbstract
[en] Iodinated contrast media (ICM) are introduced into clinical practice at beginning of the twentieth century. Adverse reactions to ICM are not rare and may be caused by toxicity or hypersensitivity reactions. These reactions are generally classified into immediate reactions or delayed reactions. The skin is the most affected organ in both. The diagnosis of ICM hypersensitivity is based on patient´s history, skin tests, in vitro tests and provocation test. The last one is a gold standard for establishing of the diagnosis. Early recognition of adverse reaction is essential for proper treatment. Therefore, the patient should be observed for at least 30 minutes. The therapy of anaphylactic or anaphylactoid reaction consists of pharmacotherapy, oxygen therapy and management of vital functions. Additionally, the value of premedication is considered to be controversial. (author)
Original Title
Precitlivenost na jodove kontrastne latky
Primary Subject
Source
18 refs., 2 figs.
Record Type
Journal Article
Journal
Dermatologia Pre Prax (Online); ISSN 1339-4207;
; v. 11(1); p. 8-10

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] A laser amplifier system for the 1.315 μm laser output from the iodine photodissociation laser oscillator is constructed, and its characteristics are investigated. The output energy of the pulsed oscillator using i-C3F7I fed into the amplifier is found 20mJ for TEMsub(00) single mode. The maximum output energy extracted from the amplifier is found to be 430mJ and the large single energy gain is 9.1, at the gas pressure 100 torr and the trigger pulse delay time for the oscillator is 5 μsec. The maximum energy extraction efficiency is 0.36 at 20 torr. (Author)
Primary Subject
Record Type
Journal Article
Journal
Sae Mulli; ISSN 0374-4914;
; v. 22(3); p. 218-222

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] The report describes the development of a radioimmunoassay for 3,3'-L-diiodothyronine (3,3'T2) which may be performed on unextracted serum. Utilizing a specific antiserum to 3,3'-L-T2-bovine serum albumin conjugates developed in rabbits, cross-reactivity was less than 0.5% with 3,5,3'-triiodothyronine (T3) and 3,3',5'-triiodothyronine (reverse T3) and less than 0.01% with thyroxine (T4). Intra-assay variation averaged 2.9% and inter-assay variation was 7.8% and 18.5% when serum samples with 3,3'T2 concentrations of 8 ng/dl and 12 ng/dl, respectively, were analyzed. Assay sensitivity was considered to be 6 ng/dl by statistical criteria. The data suggest that 3,3'T2 circulates in the serum of normal individuals and tends to parallel serum concentrations of T3, T4 and rT3 in various states of thyroid function
Primary Subject
Record Type
Journal Article
Journal
Journal of Clinical Endocrinology and Metabolism; v. 45(2); p. 339-352
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] The carbon-13 NMR data of all possible isomeric iodo-substituted thiophenes are discussed. (Author)
Original Title
C-13 NMR - spektroskopische Untersuchung von Jodthiophenen
Primary Subject
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] A rapid method for the preparation of the radioiodinated 15-(4-iodophenyl)pentadecanoic acid (p-IPPA) was developed. 131I-p-IPPA was obtained from the corresponding tin precursor and 131I-iodide using Chloramine-T as an oxidant in a radiochemical yield of 90 ± 1.4% with a radiochemical purity > 99% when performing the labeling at room temperature within a reaction time of 3 min. The study of dependences on temperature (0, 20 and 80 deg C) and reaction time (1, 3, 5, 10 and 30 min) showed no yield increase with higher temperatures and prolonged reaction times but the formation of side products. (author
Primary Subject
Source
14 refs.
Record Type
Journal Article
Journal
Journal of Radioanalytical and Nuclear Chemistry; ISSN 0236-5731;
; CODEN JRNCDM; v. 286(1); p. 231-234

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Raman- and infrared absorption spectra for iodoxibenzene from 4000 to 30 cm-1 in the solid state is described. The region 800 to 650 cm-1 and the vibration absorption bands of the IO2 groups are discussed in detail. (ARHC)
[pt]
Descreve-se o espectro de absorcao infravermelho e Raman do iodoxibenzeno de 4000 a 30 cm-1, no estado solido. Discute-se a regiao de 800 a 650 cm-1 em detalhe e as bandas de absorcao das vibracoes do grupo IO2 atribuidas. (Autor)Original Title
Espectros de absorcao infravermelho e Raman do iodoxibenzeno
Primary Subject
Record Type
Journal Article
Journal
Anais da Academia Brasileira de Ciencias; ISSN 0001-3765;
; v. 53(3); p. 487-490

Country of publication
LanguageLanguage
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
No abstract available
Original Title
Vzaimodejstvie metallicheskogo talliya s iodalkanami
Primary Subject
Source
Short note.
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] The 125I-human fibrinogen test was introduced in Hungary applying a Hungarian made equipment produced by the Gamma Works. 131 investigations have been carried out so far and the method proved to be useful for both the control of the post-operative period and the diagnosis of suspected thrombosis. (L.E.)
Original Title
Melyvenas thrombosis kimutatasa J-125 uptake teszttel
Primary Subject
Source
4 refs.
Record Type
Journal Article
Journal
Magyar Sebeszet; ISSN 0025-0295;
; v. 35(1); p. 43-46

Country of publication
BETA DECAY RADIOISOTOPES, BLOOD COAGULATION FACTORS, CARDIOVASCULAR DISEASES, DAYS LIVING RADIOISOTOPES, DISEASES, ELECTRON CAPTURE RADIOISOTOPES, GLOBULINS, INTERMEDIATE MASS NUCLEI, IODINE ISOTOPES, ISOTOPES, NUCLEI, ODD-EVEN NUCLEI, ORGANIC COMPOUNDS, ORGANIC HALOGEN COMPOUNDS, PROTEINS, RADIOISOTOPES
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Happ, J.; Griese, J.; Manegold, K.H.; Maul, F.D.; Nitz, C.; Baum, R.P.; Schwabe, D.; Gerein, V.; Klinter, D.; Szepesi, S.; Kornhuber, B.; Hoer, G.
Radioactive isotopes in clinic and research1986
Radioactive isotopes in clinic and research1986
AbstractAbstract
[en] In the treatment of adrenergic tumors with MIBG, therapeutic success depends on tumor avidity for MIBG. We recently presented a scintigraphic method for the quantification of MIBG avidity of the tumor. This method was further used in our clinical routine. The present paper reports on its significance for planning MIBG therapy, which was investigated in a larger group of patients (pts). Nine pts with neuroblastoma (NB) and a pt with metastatic pheochromocytoma (MMP) received altogether 31 therapeutic doses of MIBG. Repeat diagnostic gamma camera scintigrams were recorded and serial post-treatment scintigrams were obtained after the administration of the therapeutic doses. Background activity (BG) was determined by ROI in the left mid abdomen. Cpm obtained within standardized BG and tumor (T) ROIs were recorded and uptake ratios (UR) were calculated for the tumor (TUR) as follows: (cpmsub(T) - cpmsub(BG))/ cpmsub(BG). A close correlation was found between TUR measured after diagnostic doses and those measured after the 1st therapeutic dose up to 12 dpi. Thus, tumor avidity for a therapeutic MIBG dose could be predicted by a diagnostic dose. Serial post-treatment scintigrams at about weekly intervals showed decreasing values in most of the pts. The usefulness of determining TUR is evident especially for optimal planning of MIBG therapy, i.e. for the estimation of the radiation doses before the beginning of the treatment and for the avoidance of repeat administrations of therapeutic doses at moments of minimum avidity of the tumor for MIBG. According to our experience, rapidly growing NB should be treated with high MIBG doses given at short intervals. Therapy may be extended in MMP. (Author)
Primary Subject
Secondary Subject
Source
Hoefer, R.; Bergmann, H. (eds.); Vienna Univ. (Austria). 2. Medizinische Klinik; v. 17, pt. 1, 515 p; ISBN 3-900287-16-3;
; 1986; p. 481-486; Egermann; Vienna (Austria); Radioactive isotopes in clinic and research, Gastein international symposium 1986; Gastein (Austria); 13-16 Jan 1986

Record Type
Book
Literature Type
Conference
Country of publication
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
No abstract available
Original Title
Spektry YaKR 127I nekotorykh iodproizvodnykh ehtilena
Primary Subject
Source
Short note. For English translation see the journal Bulletin of the Academy of Sciences USSR, Division of Chemical Science (USA).
Record Type
Journal Article
Journal
Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya; ISSN 0002-3353;
; (no.4); p. 930-931

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
1 | 2 | 3 | Next |